0.38 (-%)
As of Jun 06, 2024
Source:
Neubase Therapeutics, Inc. have designed, built, and validated a new technology platform that can uniquely Drug the Genome to address the three disease-causing mechanisms, without the limitations of early precision genetic medicines.
| Country | United States |
| Headquarters | pittsburgh, pennsylvania |
| Phone Number | 412-763-3350 |
| Industry | manufacturing |
| CEO | Dietrich A. Stephan |
| Website | neubasetherapeutics.com |